Graphene has long been hailed as a "wonder material." It is incredibly strong, highly conductive and almost impossibly ...

The FDA approved the first high-concentration adalimumab biosimilar. A low-concentration version of the biosimilar, Hadlima, was already approved. Both versions will launch in July 2023. Last week, ...

These days, it feels almost impossible to concentrate — phones buzzing, screens flashing, your mind jumping from one thing to ...